Literature DB >> 9185121

The possible role of peroxynitrite in Alzheimer's disease: a simple hypothesis that could be tested more thoroughly.

K Van Dyke1.   

Abstract

Alzheimer's disease is characterized by the development of a degenerative condition in the elderly, associated with dementia. Upon pathological examination, cerebral amyloid plaques are found which contain denatured protein or peptide material. The process of denaturation of protein requires the presence of excessive heat, organic solvents, or oxidizing acids (OA). It seems that only OA could produce these effects since the other two are not present in the disease. Macrophages can produce the anion of an oxidizing acid known as peroxynitrite (OONO). This material is formed from two free radical gases, namely superoxide anion [.O2]- and nitric oxide (.N = O). Although (OONO)- is very reactive (1000 times more oxidizing than hydrogen peroxide), its half life in solution is only 1 to 2 seconds. Therefore, when it oxidizes a substance (such as protein) peroxynitrite disappears. The brain contains cells called microglia which are produced from monocytes in the same way as other types of macrophages from the lung and liver etc. The macrophages from the lung (alveolar) and liver (Kupfer cells) produce large amounts of peroxynitrite when activated by particles (silica) or infectious agents (lipopolysaccharide or interferon). Microglia produce highly oxidizing substances as well, but no one has ever measured production of peroxynitrite from these cells. Assuming that microglia produce peroxynitrite, or other similar oxidants, anti-oxidant and anti-inflammatory drugs should be helpful in treatment of early forms of the disease. In addition, large doses of anti-oxidant vitamin C and vitamin E might be helpful to people with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185121     DOI: 10.1016/s0306-9877(97)90031-1

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  Ferulic Acid Modulates Dysfunctional Metabolic Pathways and Purinergic Activities, While Stalling Redox Imbalance and Cholinergic Activities in Oxidative Brain Injury.

Authors:  Veronica F Salau; Ochuko L Erukainure; Collins U Ibeji; Tosin A Olasehinde; Neil A Koorbanally; Md Shahidul Islam
Journal:  Neurotox Res       Date:  2019-08-17       Impact factor: 3.911

2.  Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.

Authors:  K T Akama; C Albanese; R G Pestell; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia.

Authors:  Zhong Xie; Min Wei; Todd E Morgan; Paola Fabrizio; Derick Han; Caleb E Finch; Valter D Longo
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

4.  Antioxidant, antimicrobial and neuroprotective effects of Octaviania asterosperma in vitro.

Authors:  Mustafa Sevindik; Hasan Akgul; Zeliha Selamoglu; Nady Braidy
Journal:  Mycology       Date:  2020-12-02

5.  Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration.

Authors:  Ricardo M Santos; Cátia F Lourenço; Ana Ledo; Rui M Barbosa; João Laranjinha
Journal:  Int J Cell Biol       Date:  2012-06-10

Review 6.  The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.

Authors:  Shanmugam Manoharan; Gilles J Guillemin; Rajagopal Selladurai Abiramasundari; Musthafa Mohamed Essa; Mohammed Akbar; Mohammed D Akbar
Journal:  Oxid Med Cell Longev       Date:  2016-12-27       Impact factor: 6.543

Review 7.  The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.

Authors:  Sonia Sifuentes-Franco; Fermín Paul Pacheco-Moisés; Adolfo Daniel Rodríguez-Carrizalez; Alejandra Guillermina Miranda-Díaz
Journal:  J Diabetes Res       Date:  2017-10-24       Impact factor: 4.011

8.  Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer's Disease.

Authors:  Clayton A Whitmore; Justin R Haynes; William J Behof; Adam J Rosenberg; Mohammed N Tantawy; Brian C Hachey; Brian E Wadzinski; Benjamin W Spiller; Todd E Peterson; Krista C Paffenroth; Fiona E Harrison; Robert B Beelman; Printha Wijesinghe; Joanne A Matsubara; Wellington Pham
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-13

Review 9.  The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.

Authors:  Angelica Varesi; Elisa Pierella; Marcello Romeo; Gaia Bavestrello Piccini; Claudia Alfano; Geir Bjørklund; Abigail Oppong; Giovanni Ricevuti; Ciro Esposito; Salvatore Chirumbolo; Alessia Pascale
Journal:  Nutrients       Date:  2022-02-05       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.